K Pharma,Inc. (4896.T)

JPY 632.0

(-1.25%)

Annual Balance Sheets

(In JPY)
Breakdown 2023 2022 2021
Total Assets 3.31 Billion 1.37 Billion 205.76 Million
Total Current Assets 3.3 Billion 1.37 Billion 204.68 Million
Cash And Short Term Investments 3.26 Billion 1.33 Billion 188.78 Million
Cash and Cash Equivalents 3.26 Billion 1.33 Billion 188.78 Million
Short Term Investments - - -
Net Receivables 31.37 Million 22.4 Million 6.02 Million
Inventory 10.79 Million 10.19 Million 9.88 Million
Other Current Assets 392 Thousand 1.47 Million 1000.00
Total Non-Current Assets 4.93 Million 3.63 Million 1.07 Million
Net PPE - - -
Good Will And Intangible Assets - - -
Good Will - - -
Intangible Assets - - -
Long-Term Investments - - -
Tax Assets - - -
Other Non Current Assets 4.93 Million 3.63 Million 1.07 Million
Other Assets - - -
Total Liabilities 209.13 Million 38.3 Million 26.87 Million
Total Current Liabilities 178.48 Million 33.68 Million 23.37 Million
Account Payables 11.79 Million 10.04 Million 2.57 Million
Tax Payables 69.58 Million 1.9 Million 580 Thousand
Short Term Debt - - -
Deferred Revenue - - -
Other Current Liabilities 166.68 Million 23.63 Million 20.79 Million
Total Non Current Liabilities 30.65 Million 4.62 Million 3.5 Million
Long-Term Debt - - -
Deferred Revenue Non Current - - -
Deferred Tax Liabilities Non Current - - -
Other Non Current Liabilities 30.65 Million 4.62 Million 3.5 Million
Other Liabilities - - -
Total Equity 3.1 Billion 1.33 Billion 178.89 Million
Stock Holders Equity 3.1 Billion 1.33 Billion 178.89 Million
Common Stock 854.08 Million 100 Million 100 Million
Retained Earnings -752.65 Million -1.01 Billion -620.55 Million
Accumulated other comprehensive income - 1.27 Billion 499.65 Million
Common Stock Equity 3.1 Billion 1.33 Billion 178.89 Million
Capital Lease Obligation - - -
Total Investments - - -
Total Debt - - -
Net Debt -3.26 Billion -1.33 Billion -188.78 Million

Balance Sheet Charts